SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-078609
Filing Date
2016-02-02
Accepted
2016-02-02 21:21:36
Documents
1
Period of Report
2016-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 v430446_form4.html 4  
1 FORM 4 v430446_form4.xml 4 3895
  Complete submission text file 0001144204-16-078609.txt   5342
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Issuer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 90, FAIRMOUNT ROAD WEST CALIFON NJ 07830-3330
Business Address
Durrant Cameron (Reporting) CIK: 0001421882 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36602 | Film No.: 161382929